Cargando…
Prognostic value of automated bone scan index for predicting overall survival among bone metastatic castration resistant prostate cancer patients treated with radium‐223
INTRODUCTION: The objective of this study was to evaluate automated bone scan index (aBSI) as a prognostic biomarker for overall survival (OS) in bone‐metastatic, castration‐resistant prostate cancer (mCRPC) patients treated with radium‐223 (Ra‐223). MATERIALS AND METHODS: We identified 42 men treat...
Autores principales: | Miyoshi, Yasuhide, Tsutsumi, Sohgo, Kawahara, Takashi, Yasui, Masato, Uemura, Koichi, Yoneyama, Shuko, Yokomizo, Yumiko, Hayashi, Narihiko, Yao, Masahiro, Uemura, Hiroji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988825/ https://www.ncbi.nlm.nih.gov/pubmed/35474664 http://dx.doi.org/10.1002/bco2.43 |
Ejemplares similares
-
A novel prediction model for the completion of six cycles of radium-223 treatment and survival in patients with metastatic castration-resistant prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2021) -
Prognosis and safety of radium‐223 with concurrent abiraterone acetate or enzalutamide use for metastatic castration‐resistant prostate cancer: Real‐world data of Japanese patients
por: Miyoshi, Yasuhide, et al.
Publicado: (2020) -
Prognostic value of an automated bone scan index for men with metastatic castration-resistant prostate cancer treated with cabazitaxel
por: Uemura, Koichi, et al.
Publicado: (2018) -
Administration of radium‐223 and the prognosis in Japanese bone metastatic castration‐resistant prostate cancer patients: A large database study
por: Kawahara, Takashi, et al.
Publicado: (2022) -
Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer
por: Uemura, Koichi, et al.
Publicado: (2016)